Replies to post #64578 on Biotech Values

[ThomasS]

MNTA: Shouldn't we have heard something regarding this? In what manner? tia

"The appellate court has given Amphastar and Teva until 8/21/08 to respond to Sanofi’s request for an en banc rehearing that was filed in July.
Amphastar’s 180-day exclusivity clock on generic Lovenox cannot start until the court either: i) conducts the rehearing and rules on it; or ii) denies the request for a rehearing."

I would also note that news is due any day regarding the supplemental submission to the FDA.